Cosmetics
Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations
Supplements
Plant-derived exosomes, rich in nutrients, enhance bioavailability by
Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations
Supplements
Plant-derived exosomes, rich in nutrients, enhance bioavailability by
Total raised: $5.24M
Investors 1
| Date | Name | Website |
| - | Maia Ventu... | maia.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.02.2025 | Series A | $5.24M | - |
Mentions in press and media 3
| Date | Title | Description |
| 14.10.2025 | Breaking: Italy’s Maia Ventures launches $64m agrifood fund backed by EIF and others | Italy-based impact fund Maia Ventures has launched its first fund at €55 million ($64 million) that will support early-stage food and ag ventures addressing health, resilience, and efficiency in the food system. The fund is fully operationa... |
| 18.02.2025 | ExoLab Italia lands €5 million to scale plant exosome innovation globally | L’Aquila-based ExoLab Italia, a BioTech startup innovating the use of plant-derived exosomes, has secured €5 million in a Series A funding round to accelerate its industrial scale-up and international expansion The round saw investment from... |
| 18.02.2025 | ExoLab Italy Closes €5M Series A Funding | ExoLab Italy, a L’Aquila, Italy-based biotech startup specializing in the creation of products and applications based on exosomes, raised €5M in Series A funding. Backers included dsm-firmenich Ventures, CDP Venture Capital, Linfa Fund (man... |